The US Food and Drug Administration (FDA) has granted fast track status to a new drug combination for BRCA-mutated advanced breast cancer. The designation covers ART6043,...
Men and women with early Lyme disease show different symptoms, test results and clinical signs, according to a new study. The research analysed data from 243...
An electronic nose using machine learning can detect early signs of ovarian cancer in blood samples with 97 per cent accuracy, according to researchers. The device...
Very heavy or very light periods may be linked to underlying health problems that affect quality of life and can influence fertility, according to medical experts....
A non-hormonal radiofrequency treatment improved sexual function and vaginal health in postmenopausal women, according to results from a small randomised study. The study assessed nonablative capacitive-resistive...
A study of 900,000-plus patients found frail men faced a higher one-year death risk after a heart attack, although severe frailty was more common in women....
Menopause hair loss trial data showed what the company called clinically meaningful regrowth from a scalp system in a phase II study of menopausal women. The...
Most women still prefer clinic cervical screening over at-home self-sampling, despite home testing devices becoming available, a study has found. However, women who reported discrimination in...
Teijin Pharma and Aska Pharmaceutical have teamed up on small-molecule drugs research for gynaecological diseases, combining AI-led design with clinical tests. The collaboration pairs Teijin Pharma’s...
Ovarian cancer cells quickly activate survival responses after PARP inhibitor treatment, and a lung cancer drug could help block this, research suggests. PARP inhibitors are a...
